Abstract
Abstract
Introduction:
With over 20 million repairs performed worldwide annually, inguinal hernias represent a significant source of disability and loss of productivity. Natural orifice translumenal endoscopic surgery (NOTES™), as a potentially less invasive form of surgery may reduce postoperative disability and accelerate return to work. The objective of this study was to assess the safety and short-term effectiveness of transgastric inguinal herniorrhaphy using a biologic mesh in a survival canine model.
Materials and Methods:
Under general anesthesia with the animal in trendelenburg position, a gastrostomy was created. A 4 × 6 cm acellular dermal implant was deployed endoscopically across the myopectineal orifice, draped over the cord structures, and secured with Bioglue. Following completion of bilateral repairs the animals were survived for 14 days. At the end of the study period, the animals were euthanized and a necropsy performed. Cultures of a random site within the peritoneal cavity and at the site of implant deployment were obtained. In addition, a visual inspection of the peritoneal cavity was performed.
Results:
All animals thrived postoperatively and did not manifest signs of peritonitis or sepsis at any point. At necropsy accurate placement and adequate myopectineal coverage was confirmed in all subjects. Cultures of a random site within the peritoneal cavity and at the site of implant deployment had no growth.
Discussion:
This study confirms that NOTES-inguinal herniorrhaphy using a biologic implant can be performed safely. In addition, the transgastric technique provided good short-term myopectineal coverage without infectious sequelae.
Introduction
Natural orifice translumenal endoscopic surgery (NOTES) is an attractive option for IH. Since there are no skin incisions, NOTES IH can provide a truly scarless repair and could potentially reduce pain and disability. Progress toward developing NOTES versions of totally extraperitoneal or transabdominal preperitoneal IH procedures have been hampered because these techniques require complex tissue manipulation and peritoneal dissection, simply not practical with currently available endoscopic instrumentation and platforms.
Intraperitoneal onlay mesh (IPOM)4,5 is the most straightforward method for laparoscopic IH. It involves direct placement of a mesh over the inguinal defect without reduction of the hernia sac or dissection of the peritoneum. The simplicity of IPOM IH easily lends itself to a natural orifice approach.
The aim of this study was to evaluate the short-term results of NOTES IPOM bilateral IH (BIH) in a survival canine model.
Materials and Methods
This study was approved by our institution's animal use committee. Funding for this study was provided by Lifecell Incorporated (Branchburg, NJ) as an unrestricted research grant. Additional materials were provided for this study by their respective manufacturers (see Disclosure Statement section).
Five male mongrel dogs weighing 20–30 kg were used for this study. All instruments underwent high-level disinfection with 2.4% glutaraldehyde (Cidex; Johnson & Johnson, Somerville, NJ) before use. All subjects were maintained nil per os from midnight before surgery. A single dose of peri-operative intravenous antibiotics was administered (cefazolin, 1 gram IV).
The animals were placed under general anesthesia, and gastric lavage with saline solution was performed via orogastric tube until the return was clear. As described by Onders et al., 6 a Seldinger technique was used to introduce a guidewire into the gastric lumen. The wire was snared and brought out through one working channel of a dual channel gastroscope (GIF 2T100; Olympus, Tokyo, Japan). A gastrostomy was created with a sphincterotome (Hydratome RX; Boston Scientific, Natick, MA) over the guidewire. The gastrotomy was then enlarged using a 15-mm controlled radial expansion (CRE) wireguided balloon dilator (Boston Scientific). The endoscope was then introduced into the peritoneal cavity. An overtube with an insufflation channel was used. Peritoneoscopy was performed, and bilateral deep and superficial inguinal rings were identified (Fig. 1). The scope was removed, premounted with a 4 × 6 cm acellular dermal implant (AlloDerm; Lifecell) (Fig. 2), and then returned to the abdominal cavity via the overtube. The implant was then deployed across the entire myopectineal orifice and draped over the cord structures (Fig. 3). An 18-gauge needle was introduced percutaneously (Figs. 4–6), and Bioglue (CryoLife, Kennesaw, GA) was applied to secure the implant in place (Fig. 7). The gastrotomy was then closed using an endoscopic tissue approximation system (Ethicon Endosurgery, Cincinnati, OH). Following completion of bilateral repairs the animals were survived for 14 days. At the end of the study period the animals were euthanized and a necropsy was performed. Cultures of a random site within the peritoneal cavity and at the site of implant deployment were obtained. In addition, a visual inspection of the peritoneal cavity was performed.

Transgastric view of the left myopectineal orifice: cord structures (black arrow), internal ring (black arrowhead), external ring (white arrowhead), and inferior epigastric vessels (white arrow).

Dual-channel endoscope premounted with a 4 × 6 cm acellular dermal implant held by two endoscopic graspers.

The implant deployed across the myopectineal orifice and draped over the cord structures.

Bioglue applied percutaneously to each corner of the implant sequentially.

Final application of the Bioglue to the lower corner of the implant completes the hernia repair.

Final position of the implant secured in place.

Implants in position bilaterally.
Results
The mean operative time for bilateral repairs was 89 minutes (range 150–45 minutes). All animals thrived postoperatively and did not manifest signs of peritonitis or sepsis at any point. At necropsy, accurate placement and secure myopectineal coverage was confirmed in all subjects (Fig. 8). No injuries were identified at the site of gastric entry and no adhesions or abscesses were found related to the site of implantation. All cultures showed no growth.

At necropsy, accurate placement, and secure myopectineal coverage was confirmed in all subjects.
Discussion
Primary barriers to NOTES clinical adoption include difficulty maintaining spatial orientation and the lack of an adequate multitasking platform. 7 Scopes and instrumentation designed for intralumenal use are simply not up to the challenges of extralumenal surgery. Although ongoing research shows promise, 8 to date even the most basic laparoscopic procedures have not made it out of the research realm.
In stark contrast to virtually all other intra-abdominal operations, IPOM BIH does not require any significant tissue manipulation. In addition, the full range of scope maneuverability, one-to-one control, and maintenance of horizon are retained in IPOM BIH since the myopectineal orifice is located directly inline with a per-orally placed scope. Because of these notable differences between IPOM BIH and other NOTES procedures, we were able to perform all of the cases in this series with a basic gastroscope and off-the-shelf endoscopic instruments. In addition, operative times comparable to those seen with standard BIH were maintained, confirming the ready adaptability of this procedure to NOTES.
One potential shortcoming of transgastric IPOM IH is that it entails trans-oral mesh placement, which carries with it the risk of mesh infection. 9 In this survival canine study we chose a biologic implant to address this issue. We confirmed neither gross nor microscopic infection at the gastrostomy or implantation site.
The use of acellular dermis (AD) for the repair of inguinal hernias in a contaminated field has been reported with excellent short-term results. 10 AD retains its native extracellular matrix that promotes remodeling into vascularized tissue rather than instigating a foreign body reaction with encapsulation. Revascularization is likely the source of AD's ability to resist infection. 11 Adhesion formation has also been shown to be reduced even when AD is placed in direct contact with bowel. 12
This study has a number of limitations. Concerns raised by initial reports of laparoscopic IPOM include intraperitoneal adhesions and nerve and bladder injury caused by sharp intraperitoneal fixation. 13 Those early studies led to a virtual moratorium on the clinical use of the IPOM technique. Recent series using biologic glues and advanced composite meshes have not replicated these findings, generating interest once again in laparoscopic IPOM repairs, 14 but the long-term results of these novel IPOM techniques remain unknown.
Another limitation of this study is that Bioglue was used for mesh fixation. Although no adverse sequelae were noted in this series, Bioglue is not approved for intraperitoneal use and its effect on the abdominal viscera remains unknown. 15 One published series using Bioglue on pancreatic anastamoses did not report significant intra-abdominal complications, 16 but more work is needed to elucidate the role for this adhesive within the peritoneal cavity.
In conclusion, this study confirms that NOTES IPOM BIH using a biologic implant is feasible. In addition, the transgastric technique provided good short-term myopectineal coverage without infectious sequelae. NOTES IPOM BIH using a biologic implant is an interesting alternative to standard repairs and deserves further evaluation in longer-term survival studies.
Footnotes
Acknowledgment
This study was supported by an unrestricted research grant provided by the Lifecell Corporation. Additional study materials, including the Alloderm implants, Bioglue ampules, Hydratome RX sphinterotomes, CRE wireguided balloon dilators, and tissue approximation system, were provided gratis by their respective manufacturers.
Disclosure Statement
No competing financial interests exist.
